Showing results (621-630 of 855) with videos related to
Sort By:
Pageof 86
Current Hematologic Malignancy Reports|August 28, 2026
Real World Data and Its Impact on the Management of Plasma Cell DyscrasiasNaveen Subramanian, Samuel M RubinsteinCurrent Hematologic Malignancy Reports|November 6, 2022
Molecular Pathogenesis of Myeloproliferative NeoplasmsBenjamin Rolles, Ann MullallyCurrent Hematologic Malignancy Reports|October 5, 2015
Mature T-cell leukemias: Molecular and Clinical AspectsNathanael G Bailey, Kojo S J Elenitoba-JohnsonCurrent Hematologic Malignancy Reports|August 22, 2015
Immunological Consequences of JAK Inhibition: Friend or Foe?Donal P McLornan, Alesia A Khan, Claire N HarrisonCurrent Hematologic Malignancy Reports|August 17, 2015
Setting Appropriate Goals for the Next Generation of Clinical Trials in MyelofibrosisGiovanni BarosiCurrent Hematologic Malignancy Reports|August 16, 2015
Novel Induction Regimens in Multiple MyelomaKarie D Runcie, Tomer M MarkCurrent Hematologic Malignancy Reports|March 7, 2016
New Methodologies in the Molecular Monitoring of CMLCecilia C S Yeung, Daniel Egan, Jerald RadichCurrent Hematologic Malignancy Reports|February 20, 2016
How We Identify and Manage Patients with Inadequately Controlled Polycythemia VeraAndreas Reiter, Claire HarrisonCurrent Hematologic Malignancy Reports|February 23, 2016
Minimal Residual Disease Assessment in the Context of Multiple Myeloma TreatmentTaiga Nishihori, Jinming Song, Kenneth H ShainCurrent Hematologic Malignancy Reports|September 5, 2015
Immunotherapy for Multiple Myeloma, Past, Present, and Future: Monoclonal Antibodies, Vaccines, and Cellular TherapiesRebecca Karp Leaf, Hearn Jay Cho, David AviganPageof 86